CD4 and COVID-19: In this context, it is relevant to note the presence of SARS-CoV-2-reactive CD4+ T cells in recovered COVID-19 patients 65, 66, and that the development of SARS-CoV-2 reactive CD38+/HLA-DR+/CD4+ T cells strongly correlates with a positive clinical outcome 66.